Tiziana Life Sciences (TLSA)

• Market cap: $215M
• 1 day: -1.63%
• 5 days: -4.74%
• 1 month: -8.12%
• 3 months: -22.32%
• 6 months: 20.67%
• Year to date: 165.86%
• 1 year: 101.56%
• 5 years: -47.38%
• 10 years: 8.38%
• Sector: Healthcare
• Industry: Biotechnology

About: Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Employees: 9